UNSPSC 41151725: Lidocaine test system

In this classification, a Lidocaine test system is a device intended to measure Lidocaine for clinical toxicology purposes. US FDA regulates Lidocaine test system under 21 CFR 862.3555 and under FDA product code KLR

UNSPSC 41151725 Lidocaine test system is a Commodity code, yet recent state and local opportunities tagged under this code bear no relationship to lidocaine testing or pharmaceutical chemistry — the source material does not support any lidocaine-related procurement activity. The recent opportunities instead describe acquisitions of specialized scientific and research equipment spanning materials characterization systems, cold spray additive manufacturing platforms, acoustic telemetry receivers, fire alarm components, early childhood learning materials, and agricultural equipment, predominantly from Mississippi State University and the University of Mississippi, with isolated opportunities from Harris County, Texas; Escambia County, Florida; Illinois State Police; and Oregon and Wisconsin state agencies. The mismatch between the code's nominal scope and the actual goods being procured under it suggests either a systematic miscoding problem in the source data or that this code does not accurately describe current state and local purchasing activity.

Mississippi State University dominates the recent activity, filing more than twenty sole-source notices since June 2026, predominantly under the RFIN notice type with objection deadlines typically fourteen days from posting. Universities across Mississippi, Texas, and Wisconsin are soliciting major research and laboratory equipment — from $6,138 for fire alarm components to $1.253 million for a hybrid robotic 3D printing system — under competitive IFB and RFP processes as well. No recent opportunities support procurement of lidocaine test systems, and the code does not currently track state and local spending in that commodity area. Firms pursuing activity under this code classification should verify the actual commodity focus with issuing bodies before investing in pursuit, as the code label and procurement reality are substantially disconnected.